Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
20.85
-0.18 (-0.86%)
At close: Feb 6, 2026, 4:00 PM EST
21.39
+0.54 (2.59%)
After-hours: Feb 6, 2026, 6:41 PM EST
Nanobiotix Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Nanobiotix stock has a target of 26, which predicts a 24.70% increase from the current stock price of 20.85.
Price Target: $26 (+24.70%)
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for Nanobiotix is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Maintains $8 → $26 | Strong Buy | Maintains | $8 → $26 | +24.70% | Feb 6, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $12 → $8 | Strong Buy | Maintains | $12 → $8 | -61.63% | Apr 4, 2025 |
| Guggenheim | Guggenheim | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | -42.45% | Aug 28, 2024 |
| Leerink Partners | Leerink Partners | Buy Initiates $11 | Buy | Initiates | $11 | -47.24% | Dec 8, 2023 |
| Evercore ISI Group | Evercore ISI Group | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jan 6, 2021 |
Financial Forecast
Revenue This Year
28.61M
from -7.19M
Revenue Next Year
70.17M
from 28.61M
Increased by 145.24%
EPS This Year
-0.78
from -1.44
EPS Next Year
-0.87
from -0.78
Financial currency is EUR. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 34.7M | 124.1M | ||||
| Avg | 28.6M | 70.2M | ||||
| Low | 24.1M | 14.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | 333.8% | ||||
| Avg | - | 145.2% | ||||
| Low | - | -48.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.34 | -0.67 | ||||
| Avg | -0.78 | -0.87 | ||||
| Low | -1.37 | -1.00 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.